Clinical Trials Browser

Phase 3 × Active not recruiting × Colonoscopy × Clear all

NCT03233711 2026-05-13

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

Phase 3 Active not recruiting

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT00883792 2017-06-19

NordICC

Phase 3 Active not recruiting

95,000 enrolled

Gastrointestinal

Colorectal Neoplasms